FDA Inspection 1166201 — Symbiosis Gesellschaft zur Entwicklung biotechnologischer Produkte und Pharmaka und deren Vertrieb mbH
The FDA completed an inspection of Symbiosis Gesellschaft zur Entwicklung biotechnologischer Produkte und Pharmaka und deren Vertrieb mbH on April 29, 2021 in Eppelheim. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 29, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Eppelheim (Germany)
Additional Details
Mutual Recognition Agreement (MRA)